A new paradigm for optimizing HIV intervention synergy: The role of interdependence in integrating HIV prevention interventions

Journal of Acquired Immune Deficiency Syndromes

Volumn 63, Issue SUPPL. 1, 2013, Pages

  Wingood, Gina M ^a,b   Rubtsova, Anna ^a   DiClemente, Ralph J ^a,b   Metzger, David ^c   Blank, Michael ^c  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

HIV prevention interventions; Interdependence; Optimizing; Synergy

Indexed keywords

ARTICLE; COMMUNITY; HEALTH CARE ACCESS; HEALTH CARE POLICY; HIV TEST; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL CARE; ORGANIZATIONAL STRUCTURE; POLICY; PREVENTIVE MEDICINE; PRIORITY JOURNAL; PUBLIC HEALTH;

HIV; HIV INFECTIONS; HUMANS; INTEGRATIVE MEDICINE;

EID: 84880200422     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318291fff4     Document Type: Article

References (25)

1. Vermund SH, Tique JA, Cassell HM, et al. Translation of biomedical prevention strategies for HIV: prospects and pitfalls. J Acquir Immune Defic Syndr. 2013;63(Suppl 1):S12-S25.
2. Wingood GM, DiClemente RJ, Robinson-Simpson L, et al. Efficacy of an HIV intervention in reducing high-risk human papillomavirus, non-viral sexually transmitted infections, and concurrency among African American women: a randomized controlled trial. J Acquir Immune Defic Syndr. 2013;63(Suppl 1):S36-S43.
3. DiClemente RJ, Brown JL, Sales JM, Rose ES. Rate of decay in proportion of condom-protected sex acts among adolescents after participation in an HIV risk-reduction intervention. J Acquir Immune Defic Syndr. 2013;63(Suppl 1):S85-S89.
4. Blank M, Eisenberg M. Tailored treatment for HIV+ persons with mental illness: the intervention cascade. J Acquir Immune Defic Syndr. 2013;63 (Suppl 1):S44-S48.
5. Rich JD, DiClemente RJ, Levy J, et al. Correctional facilities as partners in reducing HIV disparities. J Acquir Immune Defic Syndr. 2013;63 (Suppl 1):S49-S53.
6. Latkin CA, Davey-Rothwell MA, Knowlton AR, et al. Social network approaches to recruitment, HIV prevention, medical care, and medication adherence. J Acquir Immune Defic Syndr. 2013;63(Suppl 1):S54-S58.
7. DiClemente RJ, Bradley E, Davis TL, et al. Adoption and implementation of a computer-delivered HIV/STD risk-reduction intervention for African American adolescent females seeking services at county health departments: implementation optimization is urgently needed. J Acquir Immune Defic Syndr. 2013;63(Suppl 1):S66-S71.
8. Rhodes SD, Duck S, Alonzo J, et al. Using community-based participatory research to prevent HIV disparities: assumptions and opportunities identified by the Latino Partnership. J Acquir Immune Defic Syndr. 2013; 63(Suppl 1):S32-S35.
9. Sullivan PS, Grey JA, Rosser BRS. Emerging technologies for HIV prevention for MSM: what we've learned, and ways forward. J Acquir Immune Defic Syndr. 2013;63(Suppl 1):S102-S107.
10. Glasgow RE, Eckstein ET, ElZarrad MK. Implementation science perspectives and opportunities for HIV/AIDS research: integrating science, practice and policy. J Acquir Immune Defic Syndr. 2013;63(Suppl 1):S26-S31.
11. Brown CH, Mohr DC, Gallo CG, et al. A computational future for preventing HIV in minority communities: how advanced technology can improve implementation of effective programs. J Acquir Immune Defic Syndr. 2013;63(Suppl 1):S72-S84.
12. Wingood GM, Reddy P, Lang DL, et al. Efficacy of SISTA South Africa on sexual behavior, HIV stigma and relationship control among isiXhosa women in the Western Cape Province, South Africa: results of a randomized-controlled trial. J Acquir Immune Defic Syndr. 2013;63(Suppl 1):S59-S65.
13. McLeroy KR, Bibeau D, Steckler A, et al. An ecological perspective on health promotion programs. Health Educ Behav. 1988;15:351-377.
14. Weiner BJ, Lewis MA, Clauser SB, et al. In search of synergy: strategies for combining interventions at multiple levels. J Natl Cancer Inst Monogr. 2012;44:34-41.
15. Thompson JD. Organizations in Action. New York, NY: McGraw-Hill Book Company; 1967.
16. Krakower D, Mayer KH. Engaging healthcare providers to implement HIV pre-exposure prophylaxis. Curr Opin HIV AIDS. 2012;7:593-599.
17. Paxton LA. Considerations regarding antiretroviral chemoprophylaxis and heterosexuals in generalized epidemic settings. Curr Opin HIV AIDS. 2012;7:557-562.
18. Poynten MI, Zablotska I, Grulich AE. Considerations regarding anti-retroviral chemoprophylaxis in MSM. Curr Opin HIV AIDS. 2012;7: 549-556.
19. Schackman BR, Eggman AA. Cost-effectiveness of pre-exposure prophylaxis for HIV: a review. Curr Opin HIV AIDS. 2012;7:587-592.
20. Stringer EM, Sinkala M, Stringer JSA, et al. Prevention of mother-to-child transmission of HIV in Africa: successes and challenges in scaling-up a nevirapine-based program in Lusaka, Zambia. AIDS. 2003;17:1377-1382.
21. Peltzer K, Mosala T, Shisana O, et al. Barriers to prevention of HIV transmission from mother to child (PMTCT) in a resource poor setting in the Eastern Cape, South Africa. Afr J Reprod Health. 2007;11:57-66.
22. Uwimana J, Jackson D, Hausler H, et al. Health system barriers to implementation of collaborative TB and HIV activities including prevention of mother to child transmission in South Africa. Trop Med Int Health. 2012;17:658-665.
23. Muchomba FM, Gearing RE, Simoni JM, et al. State of science of adherence in pre-exposure prophylaxis and microbicide trials. J Acquir Immune Defic Syndr. 2012;61:490-498.
24. International AIDS Society. PrEP Implementation Policy Forum. Developing Country-Level Preparation and Capacity for PrEP Implementation. 2007. Available at: http://www.iasociety.org/Web/WebContent/File/IL-F-ias-sydney-report-02.pdf. Accessed December 4, 2012.
25. Myers GM, Mayer KH. Oral preexposure anti-HIV prophylaxis for high-risk U.S. populations: current considerations in light of new findings. AIDS Patient Care STDS. 2011;25:63-71.